NCT05877716

Brief Summary

The purpose of this study is to perform a practice-based research project designed to assess whether cognition and motivated behavior in early psychosis can be addressed as key treatment goals within real-world settings by using a 12-week mobile intervention program. We will recruit participants who are receiving care for early psychosis from clinics across the United States. We will compare outcomes from participants who receive treatment at coordinated specialty care (CSC) early psychosis clinics to those that receive standard community care. A qualifying CSC program will provide comprehensive clinical services such as psychotherapy, medication management, psychoeducation, and work or education support. This study will be conducted remotely, and participants can participate at home with their own electronic devices. The aim of this study is to investigate a well-defined 12-week mobile intervention program specifically designed to target cognitive functioning and motivated behavior for individuals with early psychosis. Participants will complete a screening interview which will include diagnosis and symptom ratings, neurocognitive assessment, and self-reports of symptoms, behavior, and functioning. Then participants will be randomized to receive the 12-week mobile intervention, or an active control of treatment as usual. The investigators will test for differences in the clinical trajectories after training, and at two follow up appointments at 6 and 12 months post-training.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
2mo left

Started May 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
May 2023Jun 2026

First Submitted

Initial submission to the registry

May 17, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 26, 2023

Completed
4 days until next milestone

Study Start

First participant enrolled

May 30, 2023

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

August 21, 2025

Status Verified

August 1, 2025

Enrollment Period

3.1 years

First QC Date

May 17, 2023

Last Update Submit

August 19, 2025

Conditions

Keywords

Cognitive TrainingMotivation EnhancementFirst Episode PsychosisSchizophrenia Spectrum DisordersRemote

Outcome Measures

Primary Outcomes (11)

  • Change in Test My Brain Scores

    Test My Brain is reported as the total score on 4 cognitive domains. The Digit Symbol Matching ranges from 0 -300+, the Verbal Paired Associated ranges from 0 - 25, the Matrix Reasoning ranges from 0 - 35, and the Multiracial Face Emotion Identification Test ranges from 0 - 48. Test My Brain will be assessed at baseline, during pre-training, at 6 months, 12 months, and 18 months. Higher scores indicate higher cognitive function. Performance score is calculated based on accuracy and reaction speed.

    18 months

  • Change in Dysfunctional Attitudes Scale - Defeatist Beliefs Subscale (DAS-DB) Score

    DAS-DB is measured over 14 items with total scores ranging from 14-98, where higher scores indicate greater defeatist beliefs. DAS-DB will be assessed at baseline, 6 months, 12 months, and 18 months.

    18 months

  • Quality of Life Scale - Abbreviated

    The quality of life scale contains 9 items rated from 0 to 6, with higher scores indicating increased functioning/decreased symptom severity. Outcome is reported as 9 separate domain scores.

    18 months

  • Change in Behavioral Inhibition and Activation Scale (BIS/BAS) - BIS Score

    BIS/BAS BIS questionnaire consists of 24 items with total scores ranging from 7-28, where higher scores indicate greater sensitivity to negative aspects of goals. BIS/BAS BIS will be assessed at baseline, 6 months, 12 months, and 18 months.

    18 months

  • Change in Behavioral Inhibition and Activation Scale (BIS/BAS) - BAS Reward Responsiveness Score

    BIS/BAS BAS reward responsiveness questionnaire consists of 24 items with total scores ranging from 5-20, where higher scores indicate greater tendency to be influenced by the possibility of reward when pursuing a goal. BIS/BAS BAS reward responsiveness will be assessed at baseline, 6 months, 12 months, and 18 months.

    18 months

  • Change in Behavioral Inhibition and Activation Scale (BIS/BAS) - BAS Drive Score

    BIS/BAS BAS drive questionnaire consists of 24 items with total scores ranging from 4-16, where higher scores indicate greater persistence in efforts towards obtaining a goal. BIS/BAS BAS drive will be assessed at baseline, 6 months, 12 months, and 18 months.

    18 months

  • Change in Behavioral Inhibition and Activation Scale (BIS/BAS) - BAS Fun Seeking Score

    BIS/BAS BAS fun seeking questionnaire consists of 24 items with total scores ranging from 4-16, where higher scores indicate greater tendency to be influenced by novelty and seeking out new experiences. BIS/BAS BAS fun seeking will be assessed at baseline, 6 months, 12 months, and 18 months.

    18 months

  • Change in Motivation and Pleasure Scale - Self Report (MAPS-SR) - Social Pleasure Score

    MAPS-SR social pleasure questionnaire consists of 15 items with total scores ranging from 0-12, where higher scores indicate increased pathology in this domain. MAPS-SR social pleasure will be assessed at baseline, 6 months, 12 months, and 18 months.

    18 months

  • Change in Motivation and Pleasure Scale - Self Report (MAPS-SR) - Recreational or Work Pleasure Score

    MAPS-SR recreational or work pleasure questionnaire consists of 15 items with total scores ranging from 0-12, where higher scores indicate increased pathology in this domain. MAPS-SR recreational or work pleasure will be assessed at baseline, 6 months, 12 months, and 18 months.

    18 months

  • Change in Motivation and Pleasure Scale - Self Report (MAPS-SR) - Feelings and Motivations About Close, Caring Relationships Score

    MAPS-SR feelings and motivations about close, caring relationships questionnaire consists of 15 items with total scores ranging from 0-24, where higher scores indicate increased pathology in this domain. MAPS-SR feelings and motivations about close, caring relationships will be assessed at baseline, 6 months, 12 months, and 18 months.

    18 months

  • Change in Motivation and Pleasure Scale - Self Report (MAPS-SR) - Motivation and Effort to Engage in Activities Score

    MAPS-SR motivation and effort to engage in activities questionnaire consists of 15 items with total scores ranging from 0-24, where higher scores indicate increased pathology in this domain. MAPS-SR motivation and effort to engage in activities will be assessed at baseline, 6 months, 12 months, and 18 months.

    18 months

Secondary Outcomes (1)

  • COMPASS-10

    18 months

Other Outcomes (2)

  • BrainHQ Cognitive Training Performance Data

    12 weeks

  • Tolerability of BrainHQ Cognitive Training & PRIME

    12 weeks

Study Arms (2)

Treatment as Usual

ACTIVE COMPARATOR

Participants will be treated as usual in their early psychosis CSC program and will not complete cognitive training or use the Personalized Real-Time Motivational Enhancement App.

Other: Early Psychosis Coordinated Specialty Care

Cognitive Training plus Personalized Real-Time Intervention for Motivational Enhancement

EXPERIMENTAL

The Mobile Intervention. 20 hours of training consisting of 10 hours of cognitive training exercises plus 10 hours of social cognitive training exercises will be delivered over the course of 12 weeks. Participants will also engage in the PRIME app on a smart phone and will receive personalized support from a motivation enhancement coach.

Device: Cognitive and Social Cognitive TrainingBehavioral: Personalized Real-Time Intervention for Motivational Enhancement (PRIME) AppOther: Early Psychosis Coordinated Specialty Care

Interventions

The Cognitive Training Module is designed to improve the speed and accuracy of auditory information processing while engaging working memory and cognitive control under conditions of close attention and reward. The goal is to increase the effectiveness by which salient stimuli engage and drive plastic changes in brain systems that in individuals with psychosis exhibit relatively poor temporal response. The Social Cognition Training Module consists of exercises designed to ameliorate core deficits in social cognition expressed in schizophrenia and Autism Spectrum Disorders. The exercises apply principles of implicit learning to restore the brain's capacity to process and utilize socially-relevant information, and include training to improve affect perception, social cue perception, theory of mind, self-referential style, and emotion labeling and working memory.

Cognitive Training plus Personalized Real-Time Intervention for Motivational Enhancement

The PRIME smartphone-based app is designed to be used for 12 weeks to enhance motivation in people with early psychosis. Participants work towards self-identified goals with the support of the virtual community of age-matched peers, as well as with motivation coaches. Participants discuss their interests and aspirations with each other and with their coach, and the coach sends daily individualized motivational messages. Coaches also provide tailored interventions to enhance motivation, and post daily discussion topics to the PRIME community to encourage interaction between members. Coaches will maintain close communication and feedback on progress with each individual's clinical team.

Cognitive Training plus Personalized Real-Time Intervention for Motivational Enhancement

Participants will continue to engage in treatment as usual at their early psychosis coordinated specialty care clinic. These clinics may follow the NAVIGATE model, as an example.

Cognitive Training plus Personalized Real-Time Intervention for Motivational EnhancementTreatment as Usual

Eligibility Criteria

Age15 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Aged 15-40 (inclusive)
  • Is enrolled in an early psychosis coordinated specialty care clinic, or is receiving services by a mental health care professional.
  • Symptoms of psychosis started within the last 5 years
  • Is in good general physical health (e.g., not acutely ill or experiencing a sever/chronic illness that would impede their ability to complete study activities)
  • Fluent in spoken and written English
  • Estimated IQ at or above 70, as estimated by the Test My Brain matrices task
  • Participants will show overall clinical stability as determined by interview measures. Generally, participants who have not been hospitalized within the last 30 days, who have not had significant changes to medications, and do not have active suicidal ideation will be considered stable.
  • Has access to a smart phone or other mobile device to use the PRIME App
  • Has access to a computer or tablet to complete cognitive training exercises and study assessments

You may not qualify if:

  • Unable to provide informed consent (i.e., cannot pass UBACC assessment)
  • Participant is under legal commitment to treatment or is under medical guardianship
  • Participated in significant cognitive training programs within the last 3 years
  • Diagnosed with a neurological disorder that may interfere with participation in the study
  • Clinically significant substance abuse that is impeding the participant's ability to participate fully during enrollment, assessment, or training (i.e., is unable to remain sober)
  • Risk of suicidal behavior

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Minnesota Department of Psychiatry & Behavioral Sciences

Minneapolis, Minnesota, 55454, United States

Location

MeSH Terms

Conditions

Psychotic DisordersSchizophreniaSchizotypal Personality DisorderSchizophrenia Spectrum and Other Psychotic DisordersMental DisordersBipolar Disorder

Interventions

PRIME protocolAmyloid

Condition Hierarchy (Ancestors)

Personality DisordersBipolar and Related DisordersMood Disorders

Intervention Hierarchy (Ancestors)

Multiprotein ComplexesMacromolecular SubstancesProteinsAmino Acids, Peptides, and Proteins

Study Officials

  • Sophia Vinogradov, MD

    University of Minnesota Department of Psychiatry and Behavioral Sciences

    PRINCIPAL INVESTIGATOR
  • Piper Meyer-Kalos, PhD

    University of Minnesota Department of Psychiatry and Behavioral Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 17, 2023

First Posted

May 26, 2023

Study Start

May 30, 2023

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

August 21, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

Data will be shared with the NIH Data Archive through the EPINET Data Coordinating Center

Locations